Why the study?
Reactive angioendotheliomatosis is frequently hard to discern histologically from angiosarcoma, potentially leading to diagnostic challenges.
This case highlights the diagnostic challenge of distinguishing angiosarcoma from reactive angioendotheliomatosis and the importance of further investigation when clinical progression and histopathology are inconclusive.
Requires vigilant immunostaining for ambiguous vascular tumors; leaves open standardized diagnostic criteria for retroperitoneal angiosarcoma.
Angiosarcoma is a malignant proliferation of vascular and lymphoendothelial origin. In terms of pathology outlines, this entity may resemble other growths derived from blood vessels. Reactive angioendotheliomatosis, an intravascular proliferation, is frequently hard to discern histologically from angiosarcoma. In this study, we outline a case initially presenting with features supporting reactive angioendotheliomatosis. Clinical progression and inconclusive histopathology raised suspicion, and further investigation was decided. Computed tomography imaging revealed a large retroperitoneal tumor, and subsequent surgery with additional histological examinations of the excised mass and cutaneous samples was performed, along with immunohistostaining. As a result, diagnosis and prognosis pointed to an entirely different direction.
No takes yet. Share an insight, caveat, or question.
Douvali et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: